Lobbying disclosures · Lobbying report
PFE: second_quarter 2026 lobbying report
Issues related to FY27 health appropriations Issues related to 340B Program Issues related to drug pricing
Follow PFE- Became public
- Jul 20, 2026, 12:12 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 9:52 AM EST
Why this is connected
Exact legal-name match: PFIZER INC (https://www.sec.gov/Archives/edgar/data/78003/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/9cdc8552-13e7-4a50-83eb-10376b07ab0e/","filing_uuid":"9cdc8552-13e7-4a50-83eb-10376b07ab0e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/9cdc8552-13e7-4a50-83eb-10376b07ab0e/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"DAVID J. SCHIAPPA","dt_posted":"2026-07-20T12:12:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW","registrant_address_2":"Suite 825","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":12675,"url":"https://lda.gov/api/v1/registrants/12675/","house_registrant_id":31811,"name":"THE DUBERSTEIN GROUP INC.","description":"Consulting","address_1":"325 7th Street NW","address_2":"Suite 825","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID J. SCHIAPPA","contact_telephone":"+1 202-728-1100","dt_updated":"2026-07-24T11:16:57.603169-04:00"},"client":{"id":117689,"url":"https://lda.gov/api/v1/clients/117689/","client_id":633,"name":"PFIZER INC.","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-12-15"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to FY27 health appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59537,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"J","last_name":"SCHIAPPA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71388,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":"KATE","middle_name":"WINKLER","last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to 340B Program Issues related to drug pricing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71388,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":"KATE","middle_name":"WINKLER","last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79182,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"R","last_name":"HOWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151755,"prefix":null,"prefix_display":null,"first_name":"SAMUEL","nickname":null,"middle_name":null,"last_name":"SCALES","suffix":null,"suffix_display":null},"covered_position":"Senior Advisor, USTR (2025); Deputy Assistant, USTR (2019-2020); Coalitions Director, House Natural Resources (2015-2016)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in PFE
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
$1K–$15K · Traded Nov 26, 2024 · disclosed Aug 7, 2026 · filed 619 days later
Got $3K from the company’s PAC - Jul 21, 2026$50K–$100K
Sen. Alan Armstrong (R-OK)
$50K–$100K · Traded Mar 24, 2026 · disclosed Jul 21, 2026 · filed 119 days later
Committee overlap: HELP - Jul 16, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
$15K–$50K · Traded Jun 8, 2026 · disclosed Jul 16, 2026 · Joint
Committee overlap: HELP - May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.